S&P 500 snaps losing streak on jobless claims rise

  • Weekly jobless claims rise in line with estimates
  • Moderna, Pfizer up as FDA authorizes updated COVID boosters
  • Exxon climbs after boosting buyback program

Dec 8 (Reuters) – The S&P 500 (.SPX) closed higher on Thursday, snapping a five-session losing streak, as investors pushed the index higher after interpreting data showing a rise in weekly jobless claims as a sign the pace of interest rate hikes could soon slow.

Wall Street’s main indexes had come under pressure in recent days, with the benchmark index shedding 3.6% since the beginning of December on expectations of a longer rate-hike cycle and downbeat economic views from some top company executives.

Such thinking had also weighed on the tech-heavy Nasdaq Composite Index (.IXIC), which had posted four straight losing sessions prior to Thursday.

However, investors drew some comfort after data showed the number of Americans filing claims for jobless benefits increased moderately last week, while unemployment rolls hit a 10-month high toward the end of November.

The report follows data last Friday that showed U.S. employers hired more workers than expected in November and increased wages, spurring fears that the Fed might stick to its aggressive stance to tame decades-high inflation.

“The market has to adjust to the fact that we’re moving from a stimulus-based economy – both fiscal and monetary – into a fundamentals-based economy, and that’s what we’re grappling with right now,” said Wiley Angell, chief market strategist at Ziegler Capital Management.

The producer price index and the University of Michigan’s consumer sentiment survey on Friday and November’s consumer price data next week will also be in focus ahead of Fed’s policy decision on Dec. 14.

Investors see a 93% chance that the U.S. central bank will hike the key benchmark rate by 50 basis points to 4.25-4.50%, with the rates peaking in May 2023 at 4.92%.

The U.S. central bank has raised its policy rate by 375 basis points this year, the fastest pace since the 1980s.

Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., December 7, 2022. REUTERS/Brendan McDermid

This aggressive approach has stoked worries of a recession, with top executives of major U.S. financial institutions including JPMorgan, BlackRock and Citi forecasting a likely economic downturn in 2023.

Adding to the fears, the yield curve between the 2-year and 10-year Treasury notes has also widened in the recent days.

According to preliminary data, the S&P 500 (.SPX) gained 29.89 points, or 0.76%, to end at 3,963.81 points, while the Nasdaq Composite (.IXIC) gained 125.84 points, or 1.15%, to 11,084.39. The Dow Jones Industrial Average (.DJI) rose 174.89 points, or 0.54%, to 33,772.81.

Most of the 11 major S&P 500 sectors rose, led by a gain in technology stocks (.SPLRCT).

Most mega-cap technology and growth stocks such as Apple Inc (AAPL.O), Nvidia Corp (NVDA.O) and Amazon.com Inc (AMZN.O) rose.

Microsoft Corp (MSFT.O) ended higher, despite giving up some intraday gains after the Federal Trade Commission filed a complaint aimed at blocking the tech giant’s $69 billion bid to buy Activision Blizzard Inc . The “Call of Duty” games maker closed lower.

The energy index (.SPNY) was one of the exceptions despite Exxon Mobil Corp gaining after announcing it would expand its $30-billion share repurchase program. The sector had been under pressure in recent sessions as commodity prices slipped: U.S. crude is now hovering near its level at the start of 2022.

Meanwhile, Moderna Inc (MRNA.O) advanced after the U.S. Food and Drug Administration authorized COVID-19 shots from the vaccine maker that target both the original coronavirus and Omicron sub-variants for use in children as young as six months of age.

The regulator also approved similar guidance for fellow COVID vaccine maker Pfizer Inc (PFE.N), which rose, and its partner BioNTech, whose U.S.-listed shares gained.

Rent the Runway Inc (RENT.O) jumped after the clothing rental firm raised its 2022 revenue forecast.

Reporting by Shubham Batra, Ankika Biswas, Johann M Cherian in Bengaluru and David French in New York; Editing by Vinay Dwivedi, Sriraj Kalluvila, Anil D’Silva and Richard Chang

Our Standards: The Thomson Reuters Trust Principles.

source: reuters.com